Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19
Xavier Mariette, Olivier Hermine, Pierre‐Louis Tharaux, Matthieu Resche‐Rigon, Philippe Gabríel Steg, Raphaël Porcher, Philippe Ravaud
Abstract
This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
Topics & Concepts
MedicineTocilizumabCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEBetacoronavirusInternal medicineVirologyOutbreakRheumatoid arthritisInfectious disease (medical specialty)DiseaseLawPolitical scienceCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Vitamin C and Antioxidants Research